Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
3.620
+0.120 (3.43%)
At close: May 12, 2025, 4:00 PM
3.620
0.00 (0.00%)
After-hours: May 12, 2025, 4:00 PM EDT
Design Therapeutics Market Cap
Design Therapeutics has a market cap or net worth of $204.93 million as of May 12, 2025. Its market cap has decreased by -0.62% in one year.
Market Cap
204.93M
Enterprise Value
-20.34M
1-Year Change
-0.62%
Ranking
Category
Stock Price
$3.62
Market Cap Chart
Since the IPO on March 26, 2021, Design Therapeutics's market cap has decreased from $2.21B to $204.93M, a decrease of -90.71%. That is a compound annual growth rate of -43.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 198.69M | -43.13% |
| Dec 31, 2024 | 349.35M | 135.41% |
| Dec 29, 2023 | 148.40M | -74.10% |
| Dec 30, 2022 | 572.92M | -51.55% |
| Dec 31, 2021 | 1.18B | -46.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |